150 related articles for article (PubMed ID: 6572894)
1. Physiological and x-ray studies of potential antisickling agents.
Abraham DJ; Perutz MF; Phillips SE
Proc Natl Acad Sci U S A; 1983 Jan; 80(2):324-8. PubMed ID: 6572894
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.
Xu GG; Pagare PP; Ghatge MS; Safo RP; Gazi A; Chen Q; David T; Alabbas AB; Musayev FN; Venitz J; Zhang Y; Safo MK; Abdulmalik O
Mol Pharm; 2017 Oct; 14(10):3499-3511. PubMed ID: 28858508
[TBL] [Abstract][Full Text] [Related]
3. Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin.
Omar AM; Mahran MA; Ghatge MS; Bamane FH; Ahmed MH; El-Araby ME; Abdulmalik O; Safo MK
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529207
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and testing of antisickling agents. 2. Proline derivatives designed for the donor site.
Abraham DJ; Mokotoff M; Sheh L; Simmons JE
J Med Chem; 1983 Apr; 26(4):549-54. PubMed ID: 6834388
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids.
Patwa DC; Abraham DJ; Hung TC
Blood Cells; 1987; 12(3):589-601. PubMed ID: 3651614
[TBL] [Abstract][Full Text] [Related]
6. Development of antisickling compounds that chemically modify hemoglobin S specifically within the 2,3-diphosphoglycerate binding site.
Walder JA; Walder RY; Arnone A
J Mol Biol; 1980 Aug; 141(2):195-216. PubMed ID: 7441751
[No Abstract] [Full Text] [Related]
7. Design, synthesis, and testing of potential antisickling agents. 10. (2,2-Dimethylchroman-6-yl)alkanoic acids.
Fatope MO; Abraham DJ
J Med Chem; 1987 Nov; 30(11):1973-7. PubMed ID: 3669005
[TBL] [Abstract][Full Text] [Related]
8. Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.
Pagare PP; Ghatge MS; Musayev FN; Deshpande TM; Chen Q; Braxton C; Kim S; Venitz J; Zhang Y; Abdulmalik O; Safo MK
Bioorg Med Chem; 2018 May; 26(9):2530-2538. PubMed ID: 29655608
[TBL] [Abstract][Full Text] [Related]
9. Comparison of crystal and solution hemoglobin binding of selected antigelling agents and allosteric modifiers.
Mehanna AS; Abraham DJ
Biochemistry; 1990 Apr; 29(16):3944-52. PubMed ID: 2354165
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ
J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482
[TBL] [Abstract][Full Text] [Related]
11. Specific chemical modifications in the beta-cleft site of hemoglobin. Potential anti-sickling agents with hybrid functionalities.
Klotz IM; Haney DN; Wood LE
J Biol Chem; 1985 Dec; 260(30):16215-23. PubMed ID: 4066708
[TBL] [Abstract][Full Text] [Related]
12. Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin.
Abdulmalik O; Ghatge MS; Musayev FN; Parikh A; Chen Q; Yang J; Nnamani I; Danso-Danquah R; Eseonu DN; Asakura T; Abraham DJ; Venitz J; Safo MK
Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):920-8. PubMed ID: 22101818
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and testing of potential antisickling agents. 9. Cyclic tetrapeptide homologs as mimics of the mutation site of hemoglobin S.
Sheh L; Mokotoff M; Abraham DJ
Int J Pept Protein Res; 1987 Apr; 29(4):509-20. PubMed ID: 3596902
[TBL] [Abstract][Full Text] [Related]
14. X-ray diffraction study of the binding of the antisickling agent 12C79 to human hemoglobin.
Wireko FC; Abraham DJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2209-11. PubMed ID: 2006159
[TBL] [Abstract][Full Text] [Related]
15. Antigelling and antisickling bisphenyl oligopeptides and peptide analogues have similar structural features.
Burley SK; Wang AH; Votano JR; Rich A
Biochemistry; 1987 Aug; 26(16):5091-9. PubMed ID: 3663644
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of antisickling agents.
Franklin IM; Huehns ER
Trans R Soc Trop Med Hyg; 1980; 74(6):695-700. PubMed ID: 7210123
[No Abstract] [Full Text] [Related]
17. Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
Abraham DJ; Kennedy PE; Mehanna AS; Patwa DC; Williams FL
J Med Chem; 1984 Aug; 27(8):967-78. PubMed ID: 6747995
[TBL] [Abstract][Full Text] [Related]
18. Proton NMR studies of the molecular basis for the anti-sickling activity of non-covalent antisickling compounds.
Ho C; Russu IM
Prog Clin Biol Res; 1987; 240():59-66. PubMed ID: 3615505
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and testing of potential antisickling agents. 5. Disubstituted benzoic acids designed for the donor site and proline salicylates designed for the acceptor site.
Abraham DJ; Gazze DM; Kennedy PE; Mokotoff M
J Med Chem; 1984 Dec; 27(12):1549-59. PubMed ID: 6094807
[TBL] [Abstract][Full Text] [Related]
20. Methylisocyanate as an antisickling agent and its reaction with hemoglobin S.
Lee CK
J Biol Chem; 1976 Oct; 251(20):6226-31. PubMed ID: 977566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
